Lucas Ward
Stock Analyst at Ascendiant Capital
(1.16)
# 3,764
Out of 5,033 analysts
21
Total ratings
42.86%
Success rate
-15.91%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSCS HeartSciences | Maintains: Buy | $15 → $9 | $3.44 | +161.63% | 3 | Oct 1, 2025 | |
| ACON Aclarion | Maintains: Buy | $20 → $22 | $8.18 | +168.95% | 4 | Sep 19, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.2 → $6.5 | $2.85 | +128.07% | 4 | Sep 9, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $7 → $3 | $1.50 | +100.00% | 3 | Sep 3, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $3.4 → $3.6 | $2.47 | +45.75% | 5 | Jun 16, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $1.60 | +168,650.00% | 2 | Jul 29, 2024 |
HeartSciences
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $9
Current: $3.44
Upside: +161.63%
Aclarion
Sep 19, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $8.18
Upside: +168.95%
Vivos Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $6.2 → $6.5
Current: $2.85
Upside: +128.07%
60 Degrees Pharmaceuticals
Sep 3, 2025
Maintains: Buy
Price Target: $7 → $3
Current: $1.50
Upside: +100.00%
LiqTech International
Jun 16, 2025
Maintains: Buy
Price Target: $3.4 → $3.6
Current: $2.47
Upside: +45.75%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $1.60
Upside: +168,650.00%